[go: up one dir, main page]
More Web Proxy on the site http://driver.im/
Skip to main content

The pharmacokinetics of midazolam in man

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

Midazolam, a new water-soluble benzodiazepine, was administered as: i) 5 mg intravenously, ii) a 10-mg oral solution and iii) a 10-mg oral tablet, to six volunteers whose informed consent had been obtained. Midazolam plasma concentrations were measured using an electron-capture gas-liquid chromatographic assay. After 5-mg intravenous midazolam, subjects fell asleep within 1–2 min and continued to sleep for an average of 1.33 h. After oral midazolam intake (solution or tablets), drowsiness appeared after a average of 0.38 h (range 0.25–0.55 h) and sleep continued for an average of 1.17 h. The time to reach peak plasma midazolam concentration after the 10-mg solution dose (0.37±0.45 h) did not differe significantly (‘t’=2.04, df=10,p>0.05) from the time to reach peak plasma midazolam level after the 10-mg tablet dose (0.74±0.45 h). The terminal half-life, (t1/2), of midazolam in plasma was 1.77±0.83 h and there was no significant difference between the mean terminal half-life values obtained for the three midazolam formulations. The mean total clearance (Cl), of midazolam after 5-mg intravenous administration was 0.383±0.094 l·kg−1·h−1. The first pass effect, F, determined experimentally (0.36±0.09) indicated the substantial first pass metabolism of midazolam. The percentage of the midazolam dose excreted unchanged in urine in four subjects during the 0-8-h urine collection interval was very small (0.011%–0.028%).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
£29.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (United Kingdom)

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Archer GA, Sternbach LH (1968) The chemistry of benzodiazepines. Chem Rev 68: 747–784

    Google Scholar 

  • Gibaldi M, Perrier D (1975) In: Pharmacokinetics, vol. 1. J. Swarbrick (ed) Drugs and the pharmaceutical sciences. Marcel Dekker, New York, pp 293–296

    Google Scholar 

  • Puglisi CV, Meyer JC, D'Arconte L, Brooks MA, de Silva JAF (1978) Determination of water soluble imidazo-1,4-benzodiazepines in blood by electroncapture gas-liquid chromatography and in urine by differential pulse polarography. J Chromatogr 145: 81–96

    Google Scholar 

  • Reeves JG, Corssen G, Holcomb C (1978) Comparison of two benzodiazepines for anaesthesia induction: midazolam and diazepam. Can Anaesth Soc J 25: 211–214

    Google Scholar 

  • Sedman AJ, Wagner JG (1976) CSTRIP, a fortran IV computer program for obtaining initial polyexponential parameter estimates. J Pharm Sci 65: 1006

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Smith, M.T., Eadie, M.J. & Brophy, T.O. The pharmacokinetics of midazolam in man. Eur J Clin Pharmacol 19, 271–278 (1981). https://doi.org/10.1007/BF00562804

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00562804

Key words